DNA Methylation Profiling of the Human Major Histocompatibility Complex: A Pilot Study for the Human Epigenome Project

The Human Epigenome Project aims to identify, catalogue, and interpret genome-wide DNA methylation phenomena. Occurring naturally on cytosine bases at cytosine–guanine dinucleotides, DNA methylation is intimately involved in diverse biological processes and the aetiology of many diseases. Differentially methylated cytosines give rise to distinct profiles, thought to be specific for gene activity, tissue type, and disease state. The identification of such methylation variable positions will significantly improve our understanding of genome biology and our ability to diagnose disease. Here, we report the results of the pilot study for the Human Epigenome Project entailing the methylation analysis of the human major histocompatibility complex. This study involved the development of an integrated pipeline for high-throughput methylation analysis using bisulphite DNA sequencing, discovery of methylation variable positions, epigenotyping by matrix-assisted laser desorption/ionisation mass spectrometry, and development of an integrated public database available at http://www.epigenome.org. Our analysis of DNA methylation levels within the major histocompatibility complex, including regulatory exonic and intronic regions associated with 90 genes in multiple tissues and individuals, reveals a bimodal distribution of methylation profiles (i.e., the vast majority of the analysed regions were either hypo- or hypermethylated), tissue specificity, inter-individual variation, and correlation with independent gene expression data.

[1]  Jean L. Chang,et al.  Initial sequence of the chimpanzee genome and comparison with the human genome , 2005, Nature.

[2]  Jörn Lewin,et al.  Quantitative DNA methylation analysis based on four-dye trace data from direct sequencing of PCR amplificates , 2004, Bioinform..

[3]  I. Gut,et al.  Future potential of the Human Epigenome Project , 2004, Expert review of molecular diagnostics.

[4]  Yoshiyuki Sakaki,et al.  A comprehensive analysis of allelic methylation status of CpG islands on human chromosome 21q. , 2004, Genome research.

[5]  S. Apostolidou,et al.  An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. , 2003, Human molecular genetics.

[6]  I. Dunham,et al.  DNA sequence and analysis of human chromosome 9 , 2003, Nature.

[7]  Leif Andersson,et al.  A regulatory mutation in IGF2 causes a major QTL effect on muscle growth in the pig , 2003, Nature.

[8]  M. Leppert,et al.  Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions. , 2003, Human molecular genetics.

[9]  I. Gut,et al.  Analysis and accurate quantification of CpG methylation by MALDI mass spectrometry. , 2003, Nucleic acids research.

[10]  P. Laird.  Early detection: The power and the promise of DNA methylation markers , 2003, Nature Reviews Cancer.

[11]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[12]  I. Dunham,et al.  The DNA sequence and analysis of human chromosome 6 , 2003, Nature.

[13]  M. Groudine,et al.  DNA Methylation Density Influences the Stability of an Epigenetic Imprint and Dnmt3a/b-Independent De Novo Methylation , 2002, Molecular and Cellular Biology.

[14]  Andrew P Feinberg,et al.  A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes. , 2002, Genome research.

[15]  A. Orth,et al.  Large-scale analysis of the human and mouse transcriptomes , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[16]  A. Bird.  DNA methylation patterns and epigenetic memory. , 2002, Genes & development.

[17]  N. Rosen,et al.  The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces differentiation of human breast cancer cells. , 2001, Cancer research.

[18]  Sean R. Eddy,et al.  The Distributed Annotation System , 2001, BMC Bioinformatics.

[19]  J. Herman,et al.  Molecular detection of prostate cancer in urine by GSTP1 hypermethylation. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  Christoph Grunau,et al.  Bisulfite genomic sequencing: systematic investigation of critical experimental parameters , 2001, Nucleic Acids Res..

[21]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[22]  M. Daly,et al.  A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms , 2001, Nature.

[23]  Matthew Tudor,et al.  Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation , 2001, Nature Genetics.

[24]  International Human Genome Sequencing Consortium.  Initial sequencing and analysis of the human genome , 2001, Nature.

[25]  R. Kuick,et al.  Whole-genome methylation scan in ICF syndrome: hypomethylation of non-satellite DNA repeats D4Z4 and NBL2. , 2000, Human molecular genetics.

[26]  M. Caligiuri,et al.  Aberrant CpG-island methylation has non-random and tumour-type–specific patterns , 2000, Nature Genetics.

[27]  M. Lübbert,et al.  DNA methylation inhibitors in the treatment of leukemias, myelodysplastic syndromes and hemoglobinopathies: clinical results and possible mechanisms of action. , 2000, Current topics in microbiology and immunology.

[28]  S. Beck,et al.  From genomics to epigenomics: a loftier view of life , 1999, Nature Biotechnology.

[29]  Gen Tamiya,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999 .

[30]  Elena S. Babaylova,et al.  Complete sequence and gene map of a human major histocompatibility complex , 1999, Nature.

[31]  A. Hoffman,et al.  Dissociation of IGF2 and H19 imprinting in human brain , 1998, Brain Research.

[32]  C. Y. Yu,et al.  Four ubiquitously expressed genes, RD (D6S45)-SKI2W (SKIV2L)-DOM3Z-RP1 (D6S60E), are present between complement component genes factor B and C4 in the class III region of the HLA. , 1998, Genomics.

[33]  A. Olek,et al.  A modified and improved method for bisulphite based cytosine methylation analysis. , 1996, Nucleic acids research.

[34]  M. Bedolli,et al.  Embryonic expression of tenascin‐X suggests a role in limb, muscle, and heart development , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  H. Colten,et al.  Translational regulation of murine complement factor B alternative transcripts by upstream AUG codons. , 1995, Journal of immunology.

[36]  A. Bird,et al.  Number of CpG islands and genes in human and mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[38]  J. Volanakis,et al.  Translational regulation of complement protein C2 expression by differential utilization of the 5'-untranslated region of mRNA. , 1990, The Journal of biological chemistry.

[39]  H. Sambrook.  Molecular cloning : a laboratory manual. Cold Spring Harbor, NY , 1989 .

[40]  A. Bird.  CpG-rich islands and the function of DNA methylation , 1986, Nature.

[41]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .